Abstract:Biofilm is a structured community of bacteria encased within a self-produced extracellular matrix. When bacteria form biofilms, they undergo a phenotypic shift that enhances their resistance to antimicrobial agents. Consequently, inducing the transition of biofilm bacteria to the planktonic state may offer a viable approach for addressing infections associated with biofilms. Our previous study has shown that the mouse antimicrobial peptide CRAMP-34 can disperse Pseudomonas aeruginosa ( P. aeruginosa ) biofilm, and the potential mechanism of CRAMP-34 eradicate P. aeruginosa biofilms was also investigated by combined omics. However, changes in bacterial extracellular metabolism have not been identified. To further explore the mechanism by which CRAMP-34 disperses biofilm, this study analyzed its effects on the extracellular metabolites of biofilm cells via metabolomics. The results demonstrated that a total of 258 significantly different metabolites were detected in the untargeted metabolomics, of which 73 were downregulated and 185 were upregulated. Pathway enrichment analysis of differential metabolites revealed that metabolic pathways are mainly related to the biosynthesis and metabolism of amino acids, and it also suggested that CRAMP-34 may alter the sensitivity of biofilm bacteria to antibiotics. Subsequently, it was confirmed that the combination of CRAMP-34 with vancomycin and colistin had a synergistic effect on dispersed cells. These results, along with our previous findings, suggest that CRAMP-34 may promote the transition of PAO1 bacteria from the biofilm state to the planktonic state by upregulating the extracellular glutamate and succinate metabolism and eventually leading to the dispersal of biofilm. In addition, increased extracellular metabolites of myoinositol, palmitic acid and oleic acid may enhance the susceptibility of the dispersed bacteria to the antibiotics colistin and vancomycin. CRAMP-34 also delayed the development of bacterial resistance to colistin and ciprofloxacin. These results suggest the promising development of CRAMP-34 in combination with antibiotics as a potential candidate to provide a novel therapeutic approach for the prevention and treatment of biofilm-associated infections.

Biofilm Disruption Utilizing Α/β Chimeric Polypeptide Molecular Brushes

An Alpha/beta Chimeric Peptide Molecular Brush for Eradicating MRSA Biofilms and Persister Cells to Mitigate Antimicrobial Resistance.

Effects of a novel anti-biofilm peptide CRAMP combined with antibiotics on the formation of Pseudomonas aeruginosa biofilms

Zwitterion‐conjugated Topological Glycomimics for Dual‐Blocking Effects to Eradicate Biofilm Infection

Activity of polymyxin B combined with cefepime-avibactam against the biofilms of polymyxin B-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae in in vitro and in vivo models

Enantiomeric Glycosylated Cationic Block Co-Beta-peptides Eradicate Staphylococcus Aureus Biofilms and Antibiotic-Tolerant Persisters.

Investigation of antibiofilm activity, antibacterial activity, and mechanistic studies of an amphiphilic peptide against <i>Acinetobacter baumannii</i>

Breaching Bacterial Biofilm Barriers: Efficient Combinatorial Theranostics for Multidrug-Resistant Bacterial Biofilms with a Novel Penetration-Enhanced AIEgen Probe.

Impact of CRAMP-34 on Pseudomonas aeruginosa biofilms and extracellular metabolites

Polyzwitterionic Micelles with Antimicrobial-Conjugation for Eradication of Drug-Resistant Bacterial Biofilms.

Antibiofilm property and multiple action of peptide PEW300 against Pseudomonas aeruginosa

Harnessing antimicrobial peptide-coupled photosensitizer to combat drug-resistant biofilm infections through enhanced photodynamic therapy

Multi-targeting oligopyridiniums: Rational design for biofilm dispersion and bacterial persister eradication

Strategies for Interfering with Bacterial Early Stage Biofilms

Novel Aminothiazoximone-Corbelled Ethoxycarbonylpyrimidones with Antibiofilm Activity to Conquer Gram-negative Bacteria Through Potential Multitargeting Effects.

In-vitro Bactericidal Activity of Colistin Against Biofilm-Associated Pseudomonas Aeruginosa and Acinetobacter Baumannii

Synthesis and antibiofilm evaluation of N-acyl-2-aminopyrimidine derivatives against Acinetobacter baumannii

Biofilm Formation: Mechanistic Insights and Therapeutic Targets

Pseudomonas aeruginosa biofilm dispersion by the mouse antimicrobial peptide CRAMP

Biofilm-Sensitive Photodynamic Nanoparticles for Enhanced Penetration and Antibacterial Efficiency

Type I Photosensitizer Targeting Glycans: Overcoming Biofilm Resistance by Inhibiting the Two‐Component System, Quorum Sensing, and Multidrug Efflux